The Central Bank of Norway increased its holdings of 221,820 shares of Pharmaron Beijing (03759), with a price of approximately 20.09 Hong Kong dollars per share.
On March 12, the Central Bank of Norway increased its holdings of Kanglonghua Chengcheng (03759) by 2.2182 million shares, with a price of 20.0864 Hong Kong dollars per share, totaling approximately 445.57 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on March 12, the Central Bank of Norway increased its holding of Pharmaron Beijing (03759) by 2,212,820 shares, with a price of 20.0864 Hong Kong dollars per share, totaling approximately 445.57 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 22,959,400 shares, with a latest ownership percentage of 6.51%.
Related Articles
BBMG Corporation (02009): An Zhiqiang resigns as Vice President of the Company.
GSK's new hepatitis B drug in China is expected to be included in priority reviews and may achieve functional cure of hepatitis B.
Subsidiary of Hangzhou Kelin Electric Co. Ltd (688611.SH) signs sales contract for perovskite layered components.
BBMG Corporation (02009): An Zhiqiang resigns as Vice President of the Company.
GSK's new hepatitis B drug in China is expected to be included in priority reviews and may achieve functional cure of hepatitis B.
Subsidiary of Hangzhou Kelin Electric Co. Ltd (688611.SH) signs sales contract for perovskite layered components.
RECOMMEND
European Carmakers Embrace China: Under Technology And Cost Pressure, Stellantis And Mercedes Seek Partnerships With Chinese Automakers
17/03/2026
HKEX Listing Mechanism Reform Revisited: How To Balance New Favorites And Established Names
17/03/2026
International Oil Prices Plunge Boosts U.S. Stocks; Morgan Stanley Chief Says Market Correction Nearing End
17/03/2026
